However, an investigation aiming at constructing an immune-related lncRNAs signature in patients with LUAD showed that this signature corrected negatively with B cells, CD4+ T cells, and monocytes immune infiltration, and patients with low-risk scores had a higher abundance of immune cells and stromal cells around the tumor (Chen et al., 2021). This evidence concerns the gene CD4 and neoplasm.